Antibiotic Treatment for Infected Kidney Stones
For infected kidney stones, intravenous antimicrobial therapy with a fluoroquinolone, an aminoglycoside (with or without ampicillin), an extended-spectrum cephalosporin, or a carbapenem is recommended, with the choice based on local resistance patterns and tailored according to culture results. 1
Initial Assessment and Treatment Approach
- Infected kidney stones represent a urologic emergency when causing obstructive pyelonephritis, as this can rapidly progress to sepsis 2
- Complete stone removal is the mainstay of treatment for infected stones 2
- Always obtain urine culture before initiating antibiotics, but do not delay treatment in patients with signs of sepsis 1, 3
Empiric Antibiotic Selection
For hospitalized patients with severe infection/sepsis:
- First-line IV options:
For mild-moderate infection (outpatient management):
- Oral ciprofloxacin (500 mg twice daily) for 7 days if local resistance <10% 1
- Oral trimethoprim-sulfamethoxazole (160/800 mg twice daily for 14 days) if the pathogen is known to be susceptible 1
- Oral β-lactams are less effective but can be used if other options aren't available 1
Dosing Considerations
Fluoroquinolones:
- Ciprofloxacin: 500 mg twice daily (oral) or 400 mg IV initially
- Levofloxacin: 750 mg daily for 5-7 days 3
Carbapenems (for multi-drug resistant infections):
- Meropenem: 1g IV every 8 hours
- Dose adjustment based on renal function:
- CrCl 26-49 mL/min: 1g q12h
- CrCl 10-25 mL/min: 500mg q12h 3
Duration of Therapy
- For pyelonephritis with urinary stones: 10-14 days of therapy is recommended 1
- For complicated UTI with stones: 7-14 days depending on clinical response 3
- Shorter courses (5-7 days) may be effective with fluoroquinolones if good clinical response and the stone has been removed 3
Antibiotic Resistance Considerations
- Local resistance patterns should guide empiric therapy 1, 3
- Avoid fluoroquinolones if local resistance exceeds 10% 1
- Avoid trimethoprim-sulfamethoxazole if local resistance exceeds 20% 1, 3
- Multi-drug resistant organisms are increasingly common in urinary stone patients (32.7% in one study) 4
- Extended-spectrum beta-lactamase (ESBL) producing E. coli and K. pneumoniae are common in stone patients 4
Prophylaxis for Stone Procedures
- For patients undergoing percutaneous nephrolithotomy (PCNL) with large stones (≥20 mm) or dilated pelvicalyceal systems:
- Ciprofloxacin 250 mg twice daily for 1 week before the procedure significantly reduces the risk of upper tract infection and sepsis 5
Key Clinical Pearls
- Nitrofurantoin and ciprofloxacin show better sensitivity profiles against uropathogens in stone patients 4
- High resistance to ampicillin, penicillin, and trimethoprim-sulfamethoxazole has been observed in stone patients 4
- Female sex, history of UTI, and previous antibiotic use are risk factors for infected stones 4
- Complete stone removal is essential for definitive treatment of infection stones 2